EFFECTS OF IMMUNOMODULATORS ON THE PHARMACOKINETICS AND EFFICACY OF GOLIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM PHASE 2/3 PURSUIT –SC INDUCTION AND MAINTENANCE STUDIES

(1) Janssen R&D, LLC.

(2) 2. Centre Hospitalier Universitaire de Lille

(3) 3. Universitätsklinik für Innere Medizin IV

(4) Robarts Research Institute

(5) 5. University Hospital Gasthuisberg

(6) University of California San Diego



This item was part of the IBD: Therapy beyond anti-TNFs session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A80

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Diagnosis and Management
    • Medical management
  • Disease
    • Inflammatory bowel disease
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013